Medical Device News Magazine

Refurbishing Ventilators: A New 501(c)3 Begins Returning Tired Ventilators To Service COVID-19 Patients

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The Co-Vents team of ventilator and pulmonary experts have received expedited approval from the IRS for their 501(c)3 not-for-profit designation in just 11 days after company formation.

This designation allows Co-Vents donors to receive a tax deduction for supporting our mission of returning retired ventilators to active service for COVID-19 patients. Those interested in joining this life-saving mission can donate directly here.

Co-Vents will draw upon its founders’ long history in the manufacturing of leading-edge respiratory ventilators to refurbish “retired” ventilators and quickly bring them to market to address the pandemic of respiratory illness brought on by the coronavirus. For patients whose breathing has been significantly compromised by the virus, ventilators deliver air to the lungs to help keep these patients alive.  Our average turnaround time from ventilator donation to live clinical use will be just over a week.

“Our team is energized by the donation response that we have received to our life-saving mission,” Paul Woodring, CEO and Co-Founder of Co-Vents, said. “We are focused on closing this short-term 60-day ventilator supply gap for COVID-19 patients while new ventilator production ramps up.”

The first donated and acquired ventilators have been delivered to our designated FDA and ISO approved refurbishment facilities.  Once the FDA certification is completed, Co-Vents will work with the state and federal response teams to ensure that our ventilators are delivered to patients in the areas hardest hit by the Coronavirus.

“We are grateful to our attorneys from Charitable Allies and the IRS for working together to approve our expedited 501(c)3 request in record time.  This designation allows donors to receive a tax deduction while funding this critical mission,” Co-Founder Michael Raymer said.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.